|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile to net cash provided (used) by operating activities: | |||||
| Depreciation, depletion, and amortization | |||||
| Provision (benefit) for deferred income taxes | |||||
| Equity (earnings) losses | |||||
| Distributions from equity-method investees (Note 8) | |||||
| Other Asset Impairment Charges | |||||
| Net unrealized (gain) loss from commodity derivative instruments | |||||
| Gain on sale of business (Note 3) | |||||
| Gain on disposition of equity-method investments (Note 8) | |||||
| Gain on remeasurement of equity-method investments (Note 3) | |||||
| Inventory write-downs | |||||
| Amortization of stock-based awards | |||||
| Cash provided (used) by changes in current assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Other current assets and deferred charges | |||||
| Accounts payable | |||||
| Other current liabilities | |||||
| Changes in current and noncurrent commodity derivative assets and liabilities | |||||
| Other, including changes in noncurrent assets and liabilities | |||||
| Net cash provided (used) by operating activities | |||||
| FINANCING ACTIVITIES: | |||||
| Proceeds from (payments of) commercial paper – net | |||||
| Proceeds from long-term debt | |||||
| Payments of long-term debt | |||||
| Payments for debt issuance costs | |||||
| Proceeds from issuance of common stock | |||||
| Purchases of treasury stock | |||||
| Common dividends paid | |||||
| Dividends and distributions paid to noncontrolling interests | |||||
| Contributions from noncontrolling interests | |||||
| Total contributions from noncontrolling interests | |||||
| Other – net | |||||
| Net cash provided (used) by financing activities | |||||
| INVESTING ACTIVITIES: | |||||
| Capital expenditures (1) | |||||
| Dispositions – net | |||||
| Proceeds from sale of business (Note 3) | |||||
| Purchases of businesses, net of cash acquired (Note 3) | |||||
| Proceeds from dispositions of equity-method investments (Note 8) | |||||
| Purchases of and contributions to equity-method investments (Note 8) | |||||
| Other – net | |||||
| Net cash provided (used) by investing activities | |||||
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Additional Cash Flow Elements and Supplemental Cash Flow Information | |||||
| (1) Increases to property, plant, and equipment | |||||
| Changes in related accounts payable and accrued liabilities | |||||
Loading...